ArticleBMC cancer2018

ADAM-17 is a poor prognostic indicator for patients with hilar cholangiocarcinoma and is regulated by FoxM1.

Xiaodong Jiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.